Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Net Cash Flow (2016 - 2025)

MediWound has reported Net Cash Flow over the past 13 years, most recently at -$28.0 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 1145.52% year-over-year to -$28.0 million; the TTM value through Dec 2025 reached -$4.5 million, down 69.43%, while the annual FY2025 figure was -$4.5 million, 69.43% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$28.0 million at MediWound, down from $31.7 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $31.7 million in Q3 2025 and troughed at -$31.7 million in Q2 2023.
  • A 5-year average of -$199550.0 and a median of -$591500.0 in 2024 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: soared 1095.26% in 2021 and later plummeted 1145.52% in 2025.
  • Year by year, Net Cash Flow stood at -$2.5 million in 2021, then skyrocketed by 803.48% to $17.8 million in 2022, then tumbled by 87.58% to $2.2 million in 2023, then increased by 21.23% to $2.7 million in 2024, then plummeted by 1145.52% to -$28.0 million in 2025.
  • Business Quant data shows Net Cash Flow for MDWD at -$28.0 million in Q4 2025, $31.7 million in Q3 2025, and -$302000.0 in Q2 2025.